4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-26-012394
EVP and Chief Medical Officer sold 3,505 shares at an average $9.69 ($33,955)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark EVP and Chief Medical Officer | 2026-02-24 | Sale 10b5-1 | −1,616 | $9.53 | $15,405 | 155,913 | D |
| Eisner Mark EVP and Chief Medical Officer | 2026-02-25 | Sale 10b5-1 | −1,889 | $9.82 | $18,550 | 154,024 | D |
| Open-market sales · 3,505 sh · avg $9.69 · $33,955 | |||||||
Loading xslF345X05/wk-form4_1772142916.xml…